Company: SMNR
Filing Date: 2025-04-22
Form Type: 8-K
Source: 0001213900-25-034254
Chunk: 1

Company: Semnur Pharmaceuticals, Inc.
Filing Date: 2025-04-22
Form: 8-K
Item: Item 9.01
Chunk 1
---
Item 9.01. Financial Statements and Exhibits.

(d) Exhibits.

  Exhibit      Description                                                                                                                                                                           
   Number                                                                                                                                                                                            
      2.1      Amendment No. 1 to Agreement and Plan of Merger, dated as of April 16, 2025, by and among Denali Capital Acquisition Corp., Denali Merger Sub Inc. and Semnur Pharmaceuticals, Inc..  
 ─────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────
      104      Cover Page Interactive Data File, formatted in Inline Extensible Business Reporting Language (iXBRL).                                                                                 

SIGNATURES